Prognostic value of histologic features of toxic epidermal necrolysis

Journal of the American Academy of Dermatology

Volumn 68, Issue 2, 2013, Pages

  Valeyrie Allanore, Laurence ^a,b   Bastuji Garin, Sylvie ^b   Guégan, Sarah ^d   Ortonne, Nicolas ^c   Bagot, Martine ^e   Roujeau, Jean Claude ^a   Revuz, Jean E ^a   Wechsler, Janine ^c   Wolkenstein, Pierre ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Service de Dermatologie   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL TENON   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

full thickness necrosis; mortality; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN NECROSIS; STEVENS JOHNSON SYNDROME; SURVIVAL PREDICTION; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; DISEASE PROGRESSION; EPIDERMAL NECROLYSIS, TOXIC; EPIDERMIS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NECROSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEVENS-JOHNSON SYNDROME;

EID: 84872301246     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.10.007     Document Type: Article

References (18)

1. A.M. Stevens, and F.C. Johnson A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children Am J Dis Child 24 1922 526 533
2. L. Valeyrie-Allanore, B. Sassolas, and J.C. Roujeau Drug-induced skin, nail and hair disorders Drug Saf 30 2007 1011 1030
3. J.-C. Roujeau, and R.S. Stern Severe cutaneous adverse reactions to drugs N Engl J Med 331 1994 1272 1285
4. A. Auquier-Dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder, J.C. Roujeau SCAR Study Group Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study Arch Dermatol 138 2002 1019 1024
5. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, and T. Anderson Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 333 1995 1600 1607
6. M. Mockenhaupt, C. Viboud, A. Dunant, S. Halevy, J.N. Bouwes Bavinck, and A. Sidoroff Stevens Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs; the EuroSCAR study J Invest Dermatol 128 2008 35 44
7. S. Bastuji-Garin, B. Rzany, R.S. Stern, N.H. Shear, L. Naldi, and J.C. Roujeau Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 1993 92 96
8. S. Bastuji-Garin, N. Fouchard, M. Bertocchi, J.C. Roujeau, J. Revuz, and P. Wolkenstein SCORTEN: a severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 115 2000 149 153
9. S. Guegan, S. Bastuji-Garin, E. Poszepczynska-Guigné, J.C. Roujeau, and J. Revuz Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis J Invest Dermatol 126 2006 272 276
10. R. Cartotto, M. Mayich, D. Nickerson, and M. Gomez SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center J Burn Care Res 29 2008 141 146
11. A. Quinn, K. Brown, B. Bonish, J. Curry, K.B. Gordon, and J. Sinacore Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis Arch Dermatol 141 2005 683 687
12. P. Wolkenstein, J. Latarjet, J.C. Roujeau, C. Duguet, S. Boudeau, and L. Vaillant Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis Lancet 352 1998 1586 1589
13. N. Bachot, J. Revuz, and J.C. Roujeau Intravenous immunoglobulin treatment for Stevens-Johnson and toxic epidermal necrolysis Arch Dermatol 139 2003 33 36
14. L. Valeyrie-Allanore, P. Wolkenstein, L. Brochard, N. Ortonne, B. Maître, and J. Revuz Open trial of cyclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis Br J Dermatol 163 2010 847 853
15. Braun-Falco O. Das Lyell syndrome. Bern (Switzerland): Haus Haker Verlog, 197061-70.
16. A. Nassif, A. Bensussan, G. Dorothée, F. Mamai-Chouaib, N. Bachot, and M. Bagot Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis J Invest Dermatol 118 2002 728 733
17. W.H. Chung, S.I. Hung, J.Y. Yang, S.P. Huang, C.Y. Wei, and S.W. Chin Granulysin is a key mediator for disseminated keratinocytes death in Stevens-Johnson syndrome and toxic epidermal necrolysis Nat Med 14 2008 1343 1350
18. I. Viard, P. Werhli, R. Bullani, P. Schneider, N. Holler, and D. Salomon Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493